Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of New Genomic Tools on the Management of Patients With Multidrug-resistant Tuberculosis

NCT04397536 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.

NCT NCT04397536
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04397536 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of New Genomic Tools on the Management of Patients With Multidrug-resistant Tuberculosis
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Phase
Observational
Overall status
Unknown status
Start date
August 29, 2020
Completion date
December 1, 2022
Enrollment
172 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multi-drug resistant tuberculosis